SR ONE CAPITAL MANAGEMENT, LP Q2 2022 Filing

Filed August 2, 2022

Portfolio Value

$204.3B

Holdings

4

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (4 positions)

#StockSharesValue% PortfolioType
1
ACLXARCELLX INC.
5,500,007$99.4B48.67%
2
DSGNDESIGN THERAPEUTICS INC
5,626,476$78.8B38.55%
3
NKTXNKARTA INC.
1,333,333$16.4B8.04%
4
EFTREFFECTOR THERAPEUTICS INC
6,822,114$9.7B4.74%